{"count": 276, "results": [{"_id": "34065108", "pmid": 34065108, "pmcid": "PMC8126028", "title": "Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC", "journal": "Int J Mol Sci", "authors": ["Zhang Y", "Wang H", "Xiao H"], "date": "2021-05-09T00:00:00Z", "doi": "10.3390/ijms22095016", "meta_date_publication": "2021 May 9", "meta_volume": "22", "meta_issue": "9", "meta_pages": "", "score": 50278.836, "text_hl": "With respect to directly evaluating @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as a treatment option for @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@HCC@@@, several ongoing clinical trials combine @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ with PD-1 antibodies or others for treating @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@HCC@@@. ", "citations": {"NLM": "Zhang Y, Wang H, Xiao H. Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC Int J Mol Sci. 2021 May 9;22(9):. PMID: 34065108", "BibTeX": "@article{34065108, title={Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC}, author={Zhang Y and Wang H and Xiao H}, journal={Int J Mol Sci}, volume={22}, number={9}}"}}, {"_id": "37370771", "pmid": 37370771, "pmcid": "PMC10295995", "title": "The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?", "journal": "Cancers (Basel)", "authors": ["Papadakos SP", "Ferraro D", "Carbone G", "Frampton AE", "Vennarecci G", "Kykalos S", "Schizas D", "Theocharis S", "Machairas N"], "date": "2023-06-13T00:00:00Z", "doi": "10.3390/cancers15123161", "meta_date_publication": "2023 Jun 13", "meta_volume": "15", "meta_issue": "12", "meta_pages": "", "score": 50273.605, "text_hl": "The Emerging Role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in the Treatment of @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@Hepatocellular Carcinoma@@@: Is There Any Value in Repurposing @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ for @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@HCC@@@ Immunotherapy?", "citations": {"NLM": "Papadakos SP, Ferraro D, Carbone G, Frampton AE, Vennarecci G, Kykalos S, Schizas D, Theocharis S, Machairas N. The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy? Cancers (Basel). 2023 Jun 13;15(12):. PMID: 37370771", "BibTeX": "@article{37370771, title={The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?}, author={Papadakos SP and Ferraro D and Carbone G and Frampton AE and Vennarecci G and Kykalos S and Schizas D and Theocharis S and Machairas N}, journal={Cancers (Basel)}, volume={15}, number={12}}"}}, {"_id": "37997519", "pmid": 37997519, "pmcid": "PMC10668005", "title": "Metformin reduces hepatocarcinogenesis by inducing downregulation of Cyp26a1 and CD8+ T cells", "journal": "Clin Transl Med", "authors": ["He W", "Wang X", "Chen M", "Li C", "Chen W", "Pan L", "Cui Y", "Yu Z", "Wu G", "Yang Y", "Xu M", "Dong Z", "Ma K", "Wang J", "He Z"], "date": "2023-11-01T00:00:00Z", "doi": "10.1002/ctm2.1465", "meta_date_publication": "2023 Nov", "meta_volume": "13", "meta_issue": "11", "meta_pages": "e1465", "score": 50272.8, "text_hl": "However, despite decades of research, the mechanism underlying the @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@HCC@@@-inhibiting effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ remains a topic of debate. ", "citations": {"NLM": "He W, Wang X, Chen M, Li C, Chen W, Pan L, Cui Y, Yu Z, Wu G, Yang Y, Xu M, Dong Z, Ma K, Wang J, He Z. Metformin reduces hepatocarcinogenesis by inducing downregulation of Cyp26a1 and CD8+ T cells Clin Transl Med. 2023 Nov;13(11):e1465. PMID: 37997519", "BibTeX": "@article{37997519, title={Metformin reduces hepatocarcinogenesis by inducing downregulation of Cyp26a1 and CD8+ T cells}, author={He W and Wang X and Chen M and Li C and Chen W and Pan L and Cui Y and Yu Z and Wu G and Yang Y and Xu M and Dong Z and Ma K and Wang J and He Z}, journal={Clin Transl Med}, volume={13}, number={11}, pages={e1465}}"}}, {"_id": "32974191", "pmid": 32974191, "pmcid": "PMC7466473", "title": "Matrix Stiffness-Upregulated MicroRNA-17-5p Attenuates the Intervention Effects of Metformin on HCC Invasion and Metastasis by Targeting the PTEN/PI3K/Akt Pathway", "journal": "Front Oncol", "authors": ["Gao X", "Qiao X", "Xing X", "Huang J", "Qian J", "Wang Y", "Zhang Y", "Zhang X", "Li M", "Cui J", "Yang Y"], "date": "2020-08-19T00:00:00Z", "doi": "10.3389/fonc.2020.01563", "meta_date_publication": "2020", "meta_volume": "10", "meta_issue": "", "meta_pages": "1563", "score": 50272.41, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ significantly inhibited proliferation, migration, and invasion of @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@HCC@@@ cells. ", "citations": {"NLM": "Gao X, Qiao X, Xing X, Huang J, Qian J, Wang Y, Zhang Y, Zhang X, Li M, Cui J, Yang Y. Matrix Stiffness-Upregulated MicroRNA-17-5p Attenuates the Intervention Effects of Metformin on HCC Invasion and Metastasis by Targeting the PTEN/PI3K/Akt Pathway Front Oncol. 2020;10():1563. PMID: 32974191", "BibTeX": "@article{32974191, title={Matrix Stiffness-Upregulated MicroRNA-17-5p Attenuates the Intervention Effects of Metformin on HCC Invasion and Metastasis by Targeting the PTEN/PI3K/Akt Pathway}, author={Gao X and Qiao X and Xing X and Huang J and Qian J and Wang Y and Zhang Y and Zhang X and Li M and Cui J and Yang Y}, journal={Front Oncol}, volume={10}, pages={1563}}"}}, {"_id": "35747976", "pmid": 35747976, "title": "Recent Insights of Metformin on Hepatocellular Carcinoma (HCC).", "journal": "Mini Rev Med Chem", "authors": ["Wang K", "Zhang K", "Zhang X", "Chen D", "Jiang S"], "date": "2022-06-23T00:00:00Z", "doi": "10.2174/1389557522666220623150717", "meta_date_publication": "2022 Jun 23", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50272.01, "text_hl": "Recent Insights of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ on @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@Hepatocellular Carcinoma@@@ (@<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@HCC@@@).", "citations": {"NLM": "Wang K, Zhang K, Zhang X, Chen D, Jiang S. Recent Insights of Metformin on Hepatocellular Carcinoma (HCC). Mini Rev Med Chem. 2022 Jun 23;():. PMID: 35747976", "BibTeX": "@article{35747976, title={Recent Insights of Metformin on Hepatocellular Carcinoma (HCC).}, author={Wang K and Zhang K and Zhang X and Chen D and Jiang S}, journal={Mini Rev Med Chem}}"}}, {"_id": "37740172", "pmid": 37740172, "pmcid": "PMC10517517", "title": "Analysis of differential membrane proteins related to matrix stiffness-mediated metformin resistance in hepatocellular carcinoma cells", "journal": "Proteome Sci", "authors": ["Gao X", "Qian J", "Zhang Y", "Wang H", "Cui J", "Yang Y"], "date": "2023-09-22T00:00:00Z", "doi": "10.1186/s12953-023-00216-7", "meta_date_publication": "2023 Sep 22", "meta_volume": "21", "meta_issue": "1", "meta_pages": "14", "score": 50271.797, "text_hl": "Analysis of differential membrane proteins related to matrix stiffness-mediated @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ resistance in @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@hepatocellular carcinoma@@@ cells", "citations": {"NLM": "Gao X, Qian J, Zhang Y, Wang H, Cui J, Yang Y. Analysis of differential membrane proteins related to matrix stiffness-mediated metformin resistance in hepatocellular carcinoma cells Proteome Sci. 2023 Sep 22;21(1):14. PMID: 37740172", "BibTeX": "@article{37740172, title={Analysis of differential membrane proteins related to matrix stiffness-mediated metformin resistance in hepatocellular carcinoma cells}, author={Gao X and Qian J and Zhang Y and Wang H and Cui J and Yang Y}, journal={Proteome Sci}, volume={21}, number={1}, pages={14}}"}}, {"_id": "35897659", "pmid": 35897659, "pmcid": "PMC9329836", "title": "Metformin Enhances the Anti-Cancer Efficacy of Sorafenib via Suppressing MAPK/ERK/Stat3 Axis in Hepatocellular Carcinoma", "journal": "Int J Mol Sci", "authors": ["Siddharth S", "Kuppusamy P", "Wu Q", "Nagalingam A", "Saxena NK", "Sharma D"], "date": "2022-07-22T00:00:00Z", "doi": "10.3390/ijms23158083", "meta_date_publication": "2022 Jul 22", "meta_volume": "23", "meta_issue": "15", "meta_pages": "", "score": 50268.906, "text_hl": "Combination Treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and Morafenib Showed Superior Effects in @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@HCC@@@ Cells", "citations": {"NLM": "Siddharth S, Kuppusamy P, Wu Q, Nagalingam A, Saxena NK, Sharma D. Metformin Enhances the Anti-Cancer Efficacy of Sorafenib via Suppressing MAPK/ERK/Stat3 Axis in Hepatocellular Carcinoma Int J Mol Sci. 2022 Jul 22;23(15):. PMID: 35897659", "BibTeX": "@article{35897659, title={Metformin Enhances the Anti-Cancer Efficacy of Sorafenib via Suppressing MAPK/ERK/Stat3 Axis in Hepatocellular Carcinoma}, author={Siddharth S and Kuppusamy P and Wu Q and Nagalingam A and Saxena NK and Sharma D}, journal={Int J Mol Sci}, volume={23}, number={15}}"}}, {"_id": "38192642", "pmid": 38192642, "pmcid": "PMC10773879", "title": "Metformin: update on mechanisms of action on liver diseases", "journal": "Front Nutr", "authors": ["Ruan G", "Wu F", "Shi D", "Sun H", "Wang F", "Xu C"], "date": "2023-12-14T00:00:00Z", "doi": "10.3389/fnut.2023.1327814", "meta_date_publication": "2023", "meta_volume": "10", "meta_issue": "", "meta_pages": "1327814", "score": 50266.555, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ inhibits the growth of @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@liver cancer@@@ cells", "citations": {"NLM": "Ruan G, Wu F, Shi D, Sun H, Wang F, Xu C. Metformin: update on mechanisms of action on liver diseases Front Nutr. 2023;10():1327814. PMID: 38192642", "BibTeX": "@article{38192642, title={Metformin: update on mechanisms of action on liver diseases}, author={Ruan G and Wu F and Shi D and Sun H and Wang F and Xu C}, journal={Front Nutr}, volume={10}, pages={1327814}}"}}, {"_id": "35545330", "pmid": 35545330, "title": "Role of metformin in the diagnosis, prevention, and treatment of hepatocellular carcinoma.", "journal": "Zhong Nan Da Xue Xue Bao Yi Xue Ban", "authors": ["Xiong S", "Liu W"], "date": "2022-03-28T00:00:00Z", "doi": "10.11817/j.issn.1672-7347.2022.210118", "meta_date_publication": "2022 Mar 28", "meta_volume": "47", "meta_issue": "3", "meta_pages": "364-373", "score": 50264.594, "text_hl": "Role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in the diagnosis, prevention, and treatment of @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@hepatocellular carcinoma@@@.", "citations": {"NLM": "Xiong S, Liu W. Role of metformin in the diagnosis, prevention, and treatment of hepatocellular carcinoma. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Mar 28;47(3):364-373. PMID: 35545330", "BibTeX": "@article{35545330, title={Role of metformin in the diagnosis, prevention, and treatment of hepatocellular carcinoma.}, author={Xiong S and Liu W}, journal={Zhong Nan Da Xue Xue Bao Yi Xue Ban}, volume={47}, number={3}, pages={364-373}}"}}, {"_id": "36572351", "pmid": 36572351, "title": "Metformin in patients with hepatocellular carcinoma receiving immunotherapy.", "journal": "J Hepatol", "authors": ["Lin H", "Cheuk-Yan Yiu D", "Chin S", "Liu K", "Cheuk-Fung Yip T"], "date": "2022-12-23T00:00:00Z", "doi": "10.1016/j.jhep.2022.12.011", "meta_date_publication": "2022 Dec 23", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50264.348, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Carcinoma_Hepatocellular</m> @DISEASE_MESH:D006528 @@@hepatocellular carcinoma@@@ receiving immunotherapy.", "citations": {"NLM": "Lin H, Cheuk-Yan Yiu D, Chin S, Liu K, Cheuk-Fung Yip T. Metformin in patients with hepatocellular carcinoma receiving immunotherapy. J Hepatol. 2022 Dec 23;():. PMID: 36572351", "BibTeX": "@article{36572351, title={Metformin in patients with hepatocellular carcinoma receiving immunotherapy.}, author={Lin H and Cheuk-Yan Yiu D and Chin S and Liu K and Cheuk-Fung Yip T}, journal={J Hepatol}}"}}]}